130 related articles for article (PubMed ID: 12701958)
1. Identification of chemotherapeutic refractory cases based on human chorionic gonadotropin values among patients with low-risk persistent trophoblastic disease treated with 8-day methotrexate-folinic acid.
Shigematsu T; Hirakawa T; Yahata H; Sonoda T; Kinukawa N; Nakano H
Eur J Gynaecol Oncol; 2003; 24(2):113-6. PubMed ID: 12701958
[TBL] [Abstract][Full Text] [Related]
2. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors.
Berkowitz RS; Goldstein DP; Bernstein MR
Gynecol Oncol; 1990 Jan; 36(1):56-9. PubMed ID: 2153091
[TBL] [Abstract][Full Text] [Related]
4. Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid.
Gleeson NC; Finan MA; Fiorica JV; Robert WS; Hoffman MS; Wilson J
Eur J Gynaecol Oncol; 1993; 14(6):461-5. PubMed ID: 7514124
[TBL] [Abstract][Full Text] [Related]
5. Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.
van Trommel NE; Massuger LF; Schijf CP; ten Kate-Booij MJ; Sweep FC; Thomas CM
J Clin Oncol; 2006 Jan; 24(1):52-8. PubMed ID: 16382113
[TBL] [Abstract][Full Text] [Related]
6. Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia.
Kwon JS; Elit L; Mazurka J; Moens F; Schmuck ML
Gynecol Oncol; 2001 Aug; 82(2):367-70. PubMed ID: 11531296
[TBL] [Abstract][Full Text] [Related]
7. Medium-dose methrotrexate/folinic acid regimen in the chemotherapy of gestational trophoblastic disease.
Khoo SK; Jones IS
Med J Aust; 1980 Apr; 1(7):317-20. PubMed ID: 6248746
[TBL] [Abstract][Full Text] [Related]
8. Problems with nomenclature and pharmacodynamics in trophoblastic disease.
Kohorn EI
J Clin Oncol; 2004 Jan; 22(1):203-4; author reply 204. PubMed ID: 14701788
[No Abstract] [Full Text] [Related]
9. External validation of serum hCG cutoff levels for prediction of resistance to single-agent chemotherapy in patients with persistent trophoblastic disease.
Kerkmeijer LG; Thomas CM; Harvey R; Sweep FC; Mitchell H; Massuger LF; Seckl MJ
Br J Cancer; 2009 Mar; 100(6):979-84. PubMed ID: 19293810
[TBL] [Abstract][Full Text] [Related]
10. Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease.
Berkowitz RS; Goldstein DP; Bernstein MR
Gynecol Oncol; 1986 Jan; 23(1):111-8. PubMed ID: 3002916
[TBL] [Abstract][Full Text] [Related]
11. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
12. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
13. Trophoblastic cell sensitivity to 8-day chemotherapy in nonmetastatic gestational trophoblastic neoplasia.
Hilgers RD; Standefer JC; Rutledge JM; Ampuero F
Gynecol Oncol; 1984 Mar; 17(3):386-93. PubMed ID: 6200387
[TBL] [Abstract][Full Text] [Related]
14. High-dose methotrexate for gestational trophoblastic disease.
Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
[TBL] [Abstract][Full Text] [Related]
15. Serum methotrexate and human chorionic gonadotropin concentrations during five-day chemotherapy for low-risk metastatic gestational trophoblastic neoplasia.
Hilgers RD; Standefer JC; Bowling MC; Greeley P
Int J Gynaecol Obstet; 1988 Dec; 27(3):421-5. PubMed ID: 2904909
[TBL] [Abstract][Full Text] [Related]
16. Identification of persistent trophoblastic diseases based on a human chorionic gonadotropin regression curve by means of a stepwise piecewise linear regression analysis after the evacuation of uneventful moles.
Shigematsu T; Kamura T; Saito T; Kaku T; Nakano H; Kinugawa N
Gynecol Oncol; 1998 Dec; 71(3):376-80. PubMed ID: 9887234
[TBL] [Abstract][Full Text] [Related]
17. Plasma methotrexate levels in patients with gestational trophoblastic neoplasia treated by two methotrexate regimens.
Rotmensch J; Rosenshein N; Donehower R; Dillon M; Villar J
Am J Obstet Gynecol; 1984 Mar; 148(6):730-4. PubMed ID: 6199978
[TBL] [Abstract][Full Text] [Related]
18. Practical issues in the management of low-risk gestational trophoblast tumors.
Savage P; Seckl M; Short D
J Reprod Med; 2008 Oct; 53(10):774-80. PubMed ID: 19004403
[TBL] [Abstract][Full Text] [Related]
19. The assessment of value of transvaginal ultrasound for monitoring of gestational trophoblastic disease treatment.
Bidziñski M; Lemieszczuk B; Drabik M
Eur J Gynaecol Oncol; 1997; 18(6):541-3. PubMed ID: 9443032
[TBL] [Abstract][Full Text] [Related]
20. Poor prognosis metastatic gestational trophoblastic disease: experience with moderate dose methotrexate plus folinic acid rescue as initial therapy.
Gerulath AH; Dembo AJ; Aitken S; Quirt IC; Osborne R; Blackstein M; Rider WD
Gynecol Oncol; 1986 Nov; 25(3):294-301. PubMed ID: 3023204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
